Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic.

Autor: Kondapalli L; University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Arora G; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA., Hawi R; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA., Andrikopoulou E; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA., Estes C; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA., Patel N; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA., Lenneman CG; University of Alabama at Birmingham, UAB Heersink School of Medicine, Birmingham, AL, USA. clenneman@uabmc.edu.
Jazyk: angličtina
Zdroj: Current treatment options in oncology [Curr Treat Options Oncol] 2022 Sep; Vol. 23 (9), pp. 1288-1302. Date of Electronic Publication: 2022 Aug 15.
DOI: 10.1007/s11864-022-00997-7
Abstrakt: Opinion Statement: The COVID pandemic has transformed our approach to patient care, research, and training in cardio-oncology. While the early phases of the COVID pandemic were exceptionally frightening, we now can reflect on the innovative changes that brought more effective and patient-centered care to our doorsteps: expansion of telemedicine, integration of digital health, wider adoption of cardiac biomarkers, consolidation, and coordination of cardio-oncology testing. Normally, it takes years for health care systems to adopt new technology or modify patient care pathways; however, COVID pushed healthcare providers and the health systems to change at warp speed. All of these innovations have improved our efficacy and provided a more "patient-centered" approach for our cardio-oncology patients. The changes we have made in cardio-oncology will likely remain well beyond the pandemic and continue to grow improving the cardiovascular care of oncology patients.
(© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: